A 36 percent collapse in Cardinal Infrastructure Group’s stock price following a sharp earnings guidance cut has triggered a formal investigation by Pomerantz LLP. The firm is examining whether the company and its leadership misled shareholders regarding financial health shortly after completing a significant equity offering in June.
A 5.73% single-day stock drop following Calumet, Inc.'s second-quarter earnings report has triggered a formal investigation by Pomerantz LLP. Attorneys are now scrutinizing whether the company’s leadership misled investors regarding financial performance, specifically concerning significant margin losses and shifts in production timelines at its Montana Renewables business.
A 66.98% collapse in EyePoint’s stock value has triggered a formal investigation by Pomerantz LLP. The firm is now examining whether the company or its leadership misled shareholders regarding the pivotal LUGANO Phase 3 clinical trial results for its wet age-related macular degeneration treatment, DURAVYU.
A 26.3% plunge in Bally's Corporation stock has triggered a formal investigation by Pomerantz LLP. The inquiry centers on potential securities fraud and whether company leadership misled investors regarding the firm's financial health before a recent disclosure revealed critical liquidity concerns and a formal going concern warning.
Investors will get a look at AT&T’s financial health on October 21, 2026, when the telecommunications giant releases its third-quarter results. The company plans to publish the figures before the opening bell of the New York Stock Exchange, followed by a live conference call at 8:30 a.m. ET.
Following a sharp 23.88% drop in Criteo S.A. share prices on August 5, 2026, New York-based Pomerantz LLP has initiated an investigation into the company. The firm is examining potential securities fraud and unlawful business practices involving Criteo’s officers and directors after a bleak quarterly earnings report.
A 24.93% single-day stock plunge has triggered a formal investigation into Lincoln Educational Services Corp. by the Pomerantz Law Firm. The inquiry focuses on potential securities fraud and unlawful business practices following the company's disclosure of sluggish student enrollment growth during its second-quarter earnings report.
Dr. Alessandra Sala, Senior Director of AI and Data Science at Shutterstock, has earned a place on the 2026 TIME100 AI list. The recognition highlights her career-long pursuit of embedding ethics, transparency, and human-centric governance into the development of global artificial intelligence systems.
A 29.58% single-day stock plunge has triggered a formal investigation into Emergent BioSolutions Inc. (NYSE: EBS) by the law firm Pomerantz LLP. The probe examines whether company leadership engaged in securities fraud or unlawful business practices following a sharp reduction in revenue guidance and a massive impairment charge.
Drivers in Tennessee often face uncertainty immediately following a vehicle accident, struggling to balance insurance requirements with the need for quality repairs. Andy Spence, a collision repair expert based in Jackson, clarifies the process, emphasizing that motorists hold more control over their repair choices and claim outcomes than they realize.
The Mosaic Company board of directors has authorized a quarterly dividend payment of $0.22 per share for its common stock. This distribution marks the latest financial return for shareholders, following a formal declaration made by the Tampa-based fertilizer producer during its most recent session on August 27.
The New York Stock Exchange will host Quaker Houghton’s upcoming Investor Day on December 10, 2026, marking a strategic pivot for the global industrial process fluids leader. Management plans to outline long-term financial objectives and growth drivers during the morning session, which begins promptly at 8:30 a.m. Eastern time.
Klarna shareholders face a sharp financial reckoning after the fintech company slashed its full-year 2026 revenue forecast and announced the impending departure of its top financial and marketing executives. The sudden disclosure triggered a 22.81% collapse in the firm's share price, prompting a formal investigation by Pomerantz LLP.
FMC Corporation executives Pierre Brondeau and Andrew Sandifer are set to present at the 2026 Jefferies Global Industrials Conference on September 10. The session, scheduled for 11:30 a.m. Eastern Time, will offer investors and industry analysts insight into the agricultural sciences company's strategic outlook and current market position.
The sudden resignation of L3Harris Technologies CEO Christopher Kubasik has triggered a formal investigation by Pomerantz LLP. The firm is examining potential securities fraud and fiduciary breaches after the company confirmed that Kubasik’s departure stemmed from conduct inconsistent with its internal code of ethics.
Shareholders of First US Bancshares, Inc. are set to receive a cash dividend of $0.07 per share, following a decision by the company's Board of Directors. The payout is scheduled for October 1, 2026, for those on record as of the close of business on September 11, 2026.
A 14.95% drop in Abeona Therapeutics stock on August 13, 2026, has triggered a formal investigation by Pomerantz LLP into potential securities fraud. The firm is currently reviewing whether company leadership engaged in unlawful business practices following a disclosure regarding the revenue recognition of their ZEVASKYN therapy.
A 91.18% collapse in Sionna Therapeutics’ share price has triggered a formal investigation by Pomerantz LLP into potential securities fraud. The firm is currently reviewing whether company leadership misled investors regarding the clinical efficacy of its lead nucleotide binding domain 1 stabilizer programs.
Following the sudden resignation of Chief Executive Officer John Marotta, the Pomerantz Law Firm has initiated an investigation into Azenta, Inc. to determine if the company or its leadership engaged in securities fraud or unlawful business practices, potentially impacting shareholder value and corporate governance standards.
A series of regulatory challenges and internal billing disputes has triggered a formal investigation by Pomerantz LLP into Hims & Hers Health. The firm is examining potential securities fraud and unlawful business practices following allegations regarding the company's handling of sensitive patient data and its subscription billing policies.
A 45% collapse in share price following disappointing second-quarter results has triggered a formal investigation into AirSculpt Technologies. New York-based Pomerantz LLP is currently examining whether the company or its leadership engaged in securities fraud or unlawful business practices, potentially opening the door for a class-action lawsuit.
Investors who purchased Pentair plc securities between April 28 and July 14, 2026, face an October 2 deadline to seek appointment as lead plaintiff in a pending class action lawsuit. The litigation alleges that the company misled shareholders regarding significant inventory destocking within its pool channel.
With over 5.7 million annual visits, Midtown Village in Tuscaloosa has become the latest acquisition for JLL Income Property Trust. The Chicago-based REIT finalized the purchase of the 345,000-square-foot open-air shopping center for approximately $94 million, citing the property's prime location and stable tenant base as key drivers.
Pomerantz LLP has initiated a class action lawsuit against Fractyl Health, Inc. and its senior officers, alleging the company misled shareholders regarding the efficacy of its Revita DMR System. The litigation follows a sharp decline in share price triggered by disappointing clinical data released in early 2026.
Investors have launched a class action lawsuit against Aardvark Therapeutics, alleging the biopharmaceutical company misled shareholders about the safety and commercial viability of its lead drug candidate, ARD-101. The complaint, filed in the Southern District of California, targets disclosures made during the company’s February 2025 initial public offering.
A new class action lawsuit filed in the Northern District of Illinois alleges that Wix.com misled shareholders regarding the competitiveness and financial burden of its artificial intelligence initiatives. The complaint claims the company overstated the capabilities of its AI products while masking escalating development costs that pressured its stock price.
Investors who purchased EquipmentShare stock face a September 21 deadline to seek lead plaintiff status in a newly filed class action lawsuit. The litigation targets the company and its leadership following allegations of undisclosed related-party transactions and deceptive business practices that surfaced earlier this year.
Investors who suffered losses in GPGI, Inc. have until September 14, 2026, to seek appointment as lead plaintiff in a class action lawsuit filed by Pomerantz LLP. The litigation targets the company and its leadership over allegations of securities fraud and deceptive business practices during the past year.
A class action lawsuit filed in the U.S. District Court for the District of Massachusetts alleges that Insulet Corporation misled shareholders regarding the safety and manufacturing integrity of its Omnipod insulin delivery systems. The litigation seeks to recover damages for investors who purchased stock during a period of recurring device corrections.
Investors in Hub Group have until August 28, 2026, to seek lead plaintiff status in a class action lawsuit following the company's disclosure of material accounting misstatements. The litigation targets alleged securities fraud stemming from systemic failures in financial reporting that triggered significant drops in the firm's share price.
